Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 23 September

Bell Direct
September 23, 2024

Weekly Wrap 20 September

Bell Direct
September 20, 2024

Morning Bell 19 September

Bell Direct
September 19, 2024

Morning Bell 18 September

Bell Direct
September 18, 2024

Morning Bell 17 September

Bell Direct
September 17, 2024

Morning Bell 16 September

Bell Direct
September 16, 2024

Weekly Wrap 13 September

Bell Direct
September 13, 2024

Morning Bell 13 September

Bell Direct
September 13, 2024

Morning Bell 12 September

Bell Direct
September 12, 2024

8 minutes with 8 executives

Bell Direct
September 11, 2024

Morning Bell 11 September

Bell Direct
September 11, 2024

Morning Bell 10 September

Bell Direct
September 10, 2024